Rochester, MN, United States of America

Horng H Chen

This inventor holds 13 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Natriuretic Peptides. Top assignees: Mayo Foundation for Medical Education and Research, Nanyang Technological University, Regents of the University of Minnesota. Active years: 2012-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Horng H Chen. Retrieved from https://idiyas.com/inventor/horng-h-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 46.2

 

 

Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Natriuretic Peptides
Insulin Secreting Polypeptides
Heart Dysfunction Treatment
Renal Dysfunctions
Chimeric Peptides
Aquaretic Peptides
Restenosis Reduction
Peptide Delivery Systems
Diuretic Peptides
Vasodilatory Activity
Receptor Agonists
Blood Pressure Management
13 patents (USPTO):Explore Patents

Title: Horng H Chen: Innovator in Insulin Secretion Technologies

Introduction

Horng H Chen, a notable inventor based in Rochester, MN, has made significant contributions to the field of medical science, particularly in the area of diabetes treatment. With an impressive portfolio of 13 patents, Chen stands out as a leading figure in the development of innovative solutions to improve insulin secretion.

Latest Patents

Among his latest patents, Chen has focused on insulin secreting polypeptides. This invention describes methods and materials that relate to polypeptides capable of inducing insulin secretion. The innovation details ways to utilize these polypeptides for the effective treatment of diabetes, addressing a critical health issue affecting millions of people worldwide.

Career Highlights

Chen has had a distinguished career, contributing his expertise at prominent institutions such as the Mayo Foundation for Medical Education and Research and the University of Minnesota. His work has not only advanced scientific understanding but has also paved the way for practical applications in diabetes management.

Collaborations

Throughout his career, Chen has collaborated with esteemed colleagues, including John C Burnett, Jr and Robert D Simari. These partnerships have fostered a collaborative environment that has furthered research and development in insulin secretion technologies.

Conclusion

Horng H Chen’s innovative work continues to have a lasting impact on diabetes treatment, showcasing the power of scientific inquiry and collaboration. His contributions to insulin secreting polypeptides reflect a dedication to improving patients' lives, cementing his status as a leading inventor in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…